{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "R1441G",
        "Protein_Change": {
          "ref": "L858",
          "alt": "R1441",
          "position": "1441"
        },
        "variant_string_id": "R1441L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The study links phosphorylation of S935 to LRRK2's role in 14-3-3 binding, which is critical for PD.",
          "judgment": "Yes",
          "reasoning": "The functional assay aims to assess how phosphorylation affects LRRK2's role in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses phosphorylation assays to model LRRK2's function in PD.",
          "judgment": "Yes",
          "reasoning": "The assay is historically accepted in the field of Parkinson's disease research."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Known pathogenic variants were tested with phosphorylation assays, indicating proper controls.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type, normal, and mutant) were included in the experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath was calculated to assess pathogenicity, as phosphorylation is a direct factor in LRRK2's function.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses (OddsPath) were conducted to support the conclusion."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "All variants (R1441G, Y1699C, G2019S) are pathogenic, as their phosphorylation and binding mechanisms directly relate to Parkinson's disease pathology."
    },
    {
      "variant_id": {
        "Gene": "Y1699C",
        "Protein_Change": {
          "ref": "1699",
          "alt": "Y1699",
          "position": "1699"
        },
        "variant_string_id": "Y1699L1699"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Improving 14-3-3 binding is a key factor in PD.",
          "judgment": "Yes",
          "reasoning": "The assay aims to assess how phosphorylation affects LRRK2's role in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Phosphorylation assays model LRRK2's function in PD.",
          "judgment": "Yes",
          "reasoning": "The assay is historically accepted in Parkinson's disease research."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Known pathogenic variants were tested with phosphorylation assays, indicating proper controls.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type, normal, and mutant) were included in the experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath was calculated to assess pathogenicity, as phosphorylation is a direct factor in LRRK2's function.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses (OddsPath) were conducted to support the conclusion."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "Both Y1699C and G2019S variants are pathogenic, as their phosphorylation and binding mechanisms directly relate to Parkinson's disease pathology."
    },
    {
      "variant_id": {
        "Gene": "G2019S",
        "Protein_Change": {
          "ref": "2019",
          "alt": "G2019",
          "position": "2019"
        },
        "variant_string_id": "G2019L2019"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Impairing 14-3-3 binding is a key factor in PD.",
          "judgment": "Yes",
          "reasoning": "The assay aims to assess how phosphorylation affects LRRK2's role in PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Phosphorylation assays model LRRK2's function in PD.",
          "judgment": "Yes",
          "reasoning": "The assay is historically accepted in Parkinson's disease research."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Known pathogenic variants were tested with phosphorylation assays, indicating proper controls.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type, normal, and mutant) were included in the experiments."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath was calculated to assess pathogenicity, as phosphorylation is a direct factor in LRRK2's function.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses (OddsPath) were conducted to support the conclusion."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "All variants (G2019S, R1441G, Y1699C) are pathogenic, as their phosphorylation and binding mechanisms directly relate to Parkinson's disease pathology."
    }
  ]
}